Webinar: BBK Worldwide, Roche to Discuss the Power of mHealth October 28
Boston, Mass. – October 12, 2016 – Committed to improving patient engagement through patient-centric technologies and best-practices, BBK Worldwide is helping its clinical research partners boost clinical trial awareness and simplify the clinical trial experience. As the industry reaffirms its commitment to improving the pathways to improved clinical research, BBK Worldwide will host a webinar to discuss what’s needed to leverage the power of mHealth and related technologies to the benefit of the study and the study patient on Friday, October 28, 2016 at 12:00 p.m. ET. Joining BBK will be Lewis Millen, Operational Intelligence Leader, Roche Products Limited. Webinar details are as follows:
What: Harnessing the Power of mHealth for New, Better Data and Improved Patient Engagement
When: Friday, October 28, 2016 at 12:00 p.m. ET / 9:00 a.m. PT / 5:00 p.m. BST
Who: Matt Kibby, President, BBK Worldwide, and Lewis Millen, Operational Intelligence Leader, Roche Products Limited
How: Register here
Over the last few years, mHealth has gone from hot trend to real world and is now more widely considered a minimum requirement for reaching and engaging patients in today’s mobile-centric world. The webinar discussion will offer practical advice on employing the right mobile strategies to increase patient engagement and support smarter decisions based on larger, better data streams. The panelists will share their thoughts on what’s working and what’s not and offer real-world experiences to help attendees better understand the ways in which mHealth technologies are impacting clinical research and patient care.
About BBK Worldwide
BBK Worldwide is the foremost patient recruitment and engagement technology firm, providing a range of award-winning creative services and technology solutions to the world’s most innovative pharmaceutical and biopharmaceutical companies and their outsourced suppliers, such as CROs and eClinical providers. Committed to providing the support and solutions needed to improve patient engagement, enroll clinical studies on time, and expedite time-to-market, BBK delivers the industry’s only suite of products built from the ground up to address the patient and site engagement challenges inherent in running large, multinational studies. Headquartered near Boston, Massachusetts, BBK has partners and offices across Europe and the Asia Pacific region. For more information, visit www.bbkworldwide.com.